How Omega-3 Fats May Support Brain Health in Alzheimer’s Research
This is a scientific review article that gathers and discusses existing research on omega-3 fatty acids (EPA and DHA) and their potential relationship to Alzheimer’s disease. The authors describe how Alzheimer’s involves several interconnected processes in the brain, including protein buildup, inflammation, oxidative stress, and cellular energy problems.
The review highlights that DHA is a major structural fat found in brain cell membranes and plays a role in supporting communication between neurons. Based on prior animal and human studies, the authors note that omega-3 supplementation has been associated with reduced markers of brain protein buildup, changes in immune cell activity in the brain, and in some studies, improved cognitive performance in people with mild cognitive impairment.
The paper also explores newer, more experimental ideas about how omega-3s might interact with brain iron levels, the gut-brain connection, the brain’s waste-clearance (glymphatic) system, and small regulatory molecules called microRNAs. The authors note that results across studies have been mixed, and that individual differences in how people absorb and use omega-3s in the brain remain a challenge for researchers.
What this means for you
This review pulls together current scientific thinking on how omega-3 fatty acids might interact with brain aging processes, but it does not prove that omega-3 supplements treat or prevent Alzheimer’s disease. It’s a useful summary of research directions and open questions rather than a definitive clinical result, and individual responses to omega-3 intake appear to vary.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.